4 USD
0 (0%)
4 USD
0 (0%)
VYGR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for VYGR as it has an excellent financial health rating, but there are worries on the profitability. VYGR is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year VYGR has reported negative net income.
- VYGR had a negative operating cash flow in the past year.
- In multiple years VYGR reported negative net income over the last 5 years.
- In the past 5 years VYGR reported 4 times negative operating cash flow.
1.2 Ratios
- The Return On Assets of VYGR (-43.75%) is comparable to the rest of the industry.
- The Return On Equity of VYGR (-57.27%) is better than 63.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -43.75% | ||
| ROE | -57.27% | ||
| ROIC | N/A |
ROA(3y)-2.68%
ROA(5y)-6.15%
ROE(3y)-14.79%
ROE(5y)-19.09%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for VYGR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- VYGR does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for VYGR has been increased compared to 1 year ago.
- Compared to 5 years ago, VYGR has more shares outstanding
- VYGR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- Based on the Altman-Z score of -0.81, we must say that VYGR is in the distress zone and has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -0.81, VYGR is in line with its industry, outperforming 56.57% of the companies in the same industry.
- There is no outstanding debt for VYGR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.81 |
ROIC/WACCN/A
WACC8.88%
2.3 Liquidity
- A Current Ratio of 6.29 indicates that VYGR has no problem at all paying its short term obligations.
- With a decent Current ratio value of 6.29, VYGR is doing good in the industry, outperforming 64.19% of the companies in the same industry.
- A Quick Ratio of 6.29 indicates that VYGR has no problem at all paying its short term obligations.
- With a decent Quick ratio value of 6.29, VYGR is doing good in the industry, outperforming 65.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.29 | ||
| Quick Ratio | 6.29 |
3. Growth
3.1 Past
- The earnings per share for VYGR have decreased strongly by -404.23% in the last year.
- The Revenue for VYGR has decreased by -80.88% in the past year. This is quite bad
- Measured over the past years, VYGR shows a decrease in Revenue. The Revenue has been decreasing by -5.18% on average per year.
EPS 1Y (TTM)-404.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-193.75%
Revenue 1Y (TTM)-80.88%
Revenue growth 3Y28.85%
Revenue growth 5Y-5.18%
Sales Q2Q%-45.73%
3.2 Future
- Based on estimates for the next years, VYGR will show a decrease in Earnings Per Share. The EPS will decrease by -6.88% on average per year.
- Based on estimates for the next years, VYGR will show a decrease in Revenue. The Revenue will decrease by -8.25% on average per year.
EPS Next Y-88.71%
EPS Next 2Y-20.23%
EPS Next 3Y-8.07%
EPS Next 5Y-6.88%
Revenue Next Year-60.65%
Revenue Next 2Y-17.78%
Revenue Next 3Y-6.68%
Revenue Next 5Y-8.25%
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for VYGR. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VYGR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as VYGR's earnings are expected to decrease with -8.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.23%
EPS Next 3Y-8.07%
5. Dividend
5.1 Amount
- No dividends for VYGR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
VOYAGER THERAPEUTICS INC / VYGR FAQ
What is the fundamental rating for VYGR stock?
ChartMill assigns a fundamental rating of 2 / 10 to VYGR.
What is the valuation status of VOYAGER THERAPEUTICS INC (VYGR) stock?
ChartMill assigns a valuation rating of 0 / 10 to VOYAGER THERAPEUTICS INC (VYGR). This can be considered as Overvalued.
What is the profitability of VYGR stock?
VOYAGER THERAPEUTICS INC (VYGR) has a profitability rating of 1 / 10.
Can you provide the financial health for VYGR stock?
The financial health rating of VOYAGER THERAPEUTICS INC (VYGR) is 7 / 10.
Can you provide the expected EPS growth for VYGR stock?
The Earnings per Share (EPS) of VOYAGER THERAPEUTICS INC (VYGR) is expected to decline by -88.71% in the next year.